Robin L. Smith - 03 Sep 2021 Form 4 Insider Report for Sorrento Therapeutics, Inc.

Role
Director
Signature
/s/ Henry Ji, Ph.D., as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
03 Sep 2021
Net transactions value
+$785,250
Form type
4
Filing time
03 Sep 2021, 17:36:54 UTC
Previous filing
30 Aug 2021
Next filing
13 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRNEQ Common Stock Options Exercise $296,250 +75,000 +125% $3.95 135,000 03 Sep 2021 Direct
transaction SRNEQ Common Stock Options Exercise $489,000 +100,000 +74% $4.89 235,000 03 Sep 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRNEQ Stock Options Options Exercise $0 -75,000 -100% $0.000000* 0 03 Sep 2021 Common Stock 75,000 $3.95 Direct F1
transaction SRNEQ Stock Options Options Exercise $0 -100,000 -100% $0.000000* 0 03 Sep 2021 Common Stock 100,000 $4.89 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/12 of the original number of shares subject to this option vested and became exercisable on January 16, 2020 and 1/12 of the original number of shares subject to the option vested following each one month of service thereafter.
F2 1/12 of the original number of shares subject to this option vested and became exercisable on July 15, 2020 and 1/12 of the original number of shares subject to the option vested following each one month of service thereafter.